Breaking Down 3Peak Incorporated Financial Health: Key Insights for Investors

Breaking Down 3Peak Incorporated Financial Health: Key Insights for Investors

CN | Technology | Semiconductors | SHH

3Peak Incorporated (688536.SS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Curious whether 3Peak Incorporated (688536.SS) is a bargain or a risk-laden growth story? Peek at the facts: trailing twelve months revenue surged to CNY 1.90 billion (a 68.54% increase year-over-year) with Q3 2025 revenue of CNY 581.61 million (+70.29% YoY), yet profitability remains thin - TTM net profit margin only 1.45% and EPS of CNY 0.20 - while the market prices lofty expectations into the stock (market cap CNY 19.19 billion, P/S 10.09, trailing P/E a striking 805.14 and forward P/E 149.80); balance-sheet metrics show exceptional liquidity (current ratio 8.33, quick ratio 7.34, cash and investments ≈ CNY 3.688 billion exceeding total debt) even as 2024 recorded a CNY 197.22 million net loss and management plans an inventory impairment >CNY 92 million, setting up a tense interplay between heavy R&D-driven growth potential (forecasted revenue +27.1% p.a., EPS +77.7% p.a.) and clear near-term risks that demand closer scrutiny.

3Peak Incorporated (688536.SS) - Revenue Analysis

3Peak Incorporated reported a trailing twelve months (TTM) revenue of CNY 1.90 billion as of September 30, 2025, a substantial 68.54% increase versus the prior 12-month period. Quarterly momentum remains strong: Q3 2025 revenue was CNY 581.61 million, up 70.29% year-over-year. For full-year 2024 the company recorded CNY 1.22 billion in revenue, an 11.52% increase from 2023, illustrating accelerating growth into 2025.
  • TTM revenue (as of Sep 30, 2025): CNY 1.90 billion (+68.54% YoY)
  • Q3 2025 quarterly revenue: CNY 581.61 million (+70.29% YoY)
  • FY 2024 revenue: CNY 1.22 billion (+11.52% vs 2023)
  • Revenue per employee: CNY 2.29 million (830 employees)
  • Price-to-sales (P/S) ratio: 10.09
  • Market capitalization: CNY 19.19 billion; share price: CNY 140.55 (as of Dec 18, 2025)
Revenue drivers and operational context:
  • Scaling sales channels and likely higher average selling prices contributing to the sharp TTM and Q3 growth.
  • Operational leverage: revenue per employee of CNY 2.29 million suggests efficient revenue generation relative to headcount.
  • Market valuation reflects growth expectations: P/S of 10.09 implies investors are pricing in continued high revenue growth.
Metric Value Period / Note
TTM Revenue CNY 1.90 billion As of Sep 30, 2025 (+68.54% YoY)
Q3 2025 Revenue CNY 581.61 million +70.29% YoY
FY 2024 Revenue CNY 1.22 billion +11.52% vs 2023
Revenue per Employee CNY 2.29 million 830 employees
Price-to-Sales (P/S) 10.09 Market-implied growth premium
Market Capitalization CNY 19.19 billion Share price CNY 140.55 (Dec 18, 2025)
For broader investor context and shareholder composition, see: Exploring 3Peak Incorporated Investor Profile: Who's Buying and Why?

3Peak Incorporated (688536.SS) - Profitability Metrics

3Peak Incorporated (688536.SS) presents a mixed profitability profile: healthy gross margins contrast with modest net profitability and very low returns on equity. The company generates positive operating cash flow, supporting ongoing operations despite thin net margins.

  • Net profit margin (TTM): 1.45% - modest profitability relative to revenue.
  • EPS (TTM): CNY 0.20.
  • Net income (latest quarter ended 30 Sep 2025): CNY 27.52 million.
  • Return on equity (ROE): 0.49% - low returns to shareholders.
  • Gross profit margin: 41.50% - strong buffer above cost of goods sold.
  • Operating cash flow: positive - company generates cash from core operations.
Metric Value Period
Net Profit Margin 1.45% Trailing Twelve Months
EPS CNY 0.20 Trailing Twelve Months
Net Income (quarter) CNY 27.52 million Quarter ended 30 Sep 2025
Return on Equity (ROE) 0.49% Most recent reported
Gross Profit Margin 41.50% Most recent reported
Operating Cash Flow Positive (reported) Most recent reported

Key implications for investors:

  • High gross margin (41.50%) indicates strong pricing power or favorable cost structure at the gross level.
  • Thin net margin (1.45%) and low ROE (0.49%) signal material operating or non-operating costs, tax, or financing pressures that dilute bottom-line returns.
  • Positive operating cash flow reduces short-term liquidity concerns and provides flexibility for capex, debt servicing, or strategic investment.
  • Quarterly net income of CNY 27.52 million and TTM EPS of CNY 0.20 provide a snapshot of modest earnings capacity; monitor trend consistency.

For corporate direction and values that may influence long-term profitability see: Mission Statement, Vision, & Core Values (2026) of 3Peak Incorporated.

3Peak Incorporated (688536.SS) - Debt vs. Equity Structure

3Peak Incorporated's balance sheet shows a conservative leverage profile with substantial liquidity and equity attributable to the parent at CNY 530.27 million.
  • Debt-to-equity ratio: 0.06, indicating very low leverage.
  • Cash and investments (~CNY 3,688.00 million) exceed total debt, supporting a strong liquidity position.
  • Debt coverage by operating cash flow: 53.9% (coverage ratio reported).
  • Interest coverage ratio: insufficiently reported to assess interest payment capacity.
  • Equity attributable to parent: CNY 530.27 million, down 4.95% vs. prior period.
Metric Value Notes
Total debt (approx.) CNY 31.82 million Derived from debt-to-equity 0.06 × equity CNY 530.27m
Cash & investments CNY 3,688.00 million Reported cash/investment balances
Equity attributable to parent CNY 530.27 million -4.95% vs. prior period
Operating cash flow (implied) ~CNY 17.16 million Implied by coverage ratio 53.9% of total debt
Debt-to-equity ratio 0.06 Low leverage
Interest coverage ratio Not reported / N/A Insufficient disclosure to calculate
  • Implication: cash holdings (~CNY 3.688bn) dwarf debt (~CNY 31.82m), providing a wide margin for operations, investments, or debt reduction.
  • Equity decline of 4.95% warrants monitoring alongside retained earnings and other equity movements in subsequent reports.
  • Absent or incomplete interest coverage disclosure increases reliance on cash and operating cash flow metrics for stress testing.
3Peak Incorporated: History, Ownership, Mission, How It Works & Makes Money

3Peak Incorporated (688536.SS) - Liquidity and Solvency

3Peak Incorporated presents a strong short-term liquidity profile and solid solvency indicators based on the latest reported figures.
  • Current ratio: 8.33 - markedly above typical healthy thresholds, indicating ample short-term asset coverage of current liabilities.
  • Quick ratio: 7.34 - confirms liquidity strength even excluding inventory, showing the company can meet near-term obligations without relying on stock turnover.
  • Short-term assets exceed short-term liabilities by CNY 4.6 billion - a substantial buffer for working capital needs.
  • Short-term assets exceed long-term liabilities by CNY 4.6 billion - signalling that liquid assets alone could cover longer-dated obligations if required.
  • Operating cash flow: positive - operations are generating cash, supporting ongoing liquidity and reducing reliance on financing.
  • Interest coverage ratio: insufficiently reported - cannot reliably assess interest payment capacity from available disclosures.
Metric Value Unit / Notes
Current Ratio 8.33 Times
Quick Ratio 7.34 Times (ex-inventory)
Short-term assets minus short-term liabilities 4.6 bn CNY
Short-term assets minus long-term liabilities 4.6 bn CNY
Operating Cash Flow Positive Reported (amount per latest statement)
Interest Coverage Ratio Not sufficiently reported Cannot compute reliably from disclosures
Key implications for investors:
  • High current and quick ratios indicate low short-term liquidity risk and significant flexibility for meeting payables and opportunistic investments.
  • The CNY 4.6 billion excess of short-term assets over both short- and long-term liabilities provides a meaningful cushion against shocks or cyclical downturns.
  • Positive operating cash flow supports internal financing of operations and reduces immediate dependence on external debt, although the missing interest coverage metric warrants caution for debt-service analysis.
Mission Statement, Vision, & Core Values (2026) of 3Peak Incorporated.

3Peak Incorporated (688536.SS) Valuation Analysis

3Peak Incorporated (688536.SS) currently shows valuation metrics that indicate very high market expectations for future profitability relative to current earnings and book value, with some gaps in available enterprise multiples limiting a full operating-performance comparison.

  • Trailing P/E: 805.14 - extreme multiple driven by minimal trailing earnings or a temporary earnings trough.
  • Forward P/E: 149.80 - substantially lower than trailing P/E but still elevated, implying analysts expect earnings recovery/growth.
  • Price-to-Book (P/B): 3.80 - market values the company at nearly four times its book equity, signaling investor willingness to pay a premium for intangible assets, growth prospects, or returns above book value.
  • EV/Sales: 9.88 - the enterprise is valued at almost 10x revenue, suggesting high expectations for margins expansion or strong recurring revenue quality.
  • EV/EBITDA: not available - prevents direct enterprise-level earnings yield comparison with peers.
  • EV/EBIT: not available - limits assessment of capital structure-neutral operating profitability.
Metric Value Implication
Trailing P/E 805.14 Indicative of near-zero trailing EPS or one-off write-downs; very high market multiple
Forward P/E 149.80 Analyst-implied recovery/growth but still pricey versus broad market
Price-to-Book 3.80 Market pays a premium to book - growth or intangible asset valuation
EV/Sales 9.88 High revenue multiple; suggests expectations for strong margin improvement or high revenue quality
EV/EBITDA - Data unavailable
EV/EBIT - Data unavailable

Key investor considerations:

  • High trailing and forward P/E ratios signal that downside earnings surprises could sharply compress the stock; conversely, execution above current forecasts could justify the premium.
  • P/B of 3.8 and EV/Sales near 10x make relative-value comparison vs. industry peers essential-look for superior growth rates, margin targets, or unique competitive advantages to justify these multiples.
  • Missing EV/EBITDA and EV/EBIT requires digging into reported EBITDA, adjusted operating income, and potential one-offs to construct enterprise-level valuation assessments manually.
  • Monitor upcoming quarterly guidance and analyst revisions; moving from a trailing P/E of 805.14 to forward P/E of 149.80 already reflects expected material earnings improvement-track whether realized performance aligns.

For more context on investor composition and buying rationale, see: Exploring 3Peak Incorporated Investor Profile: Who's Buying and Why?

3Peak Incorporated (688536.SS) Risk Factors

3Peak Incorporated reported a sharp deterioration in profitability in 2024, with several company-specific and industry-level risks that investors should weigh carefully.
Metric 2024 2023 Year-on-Year Change
Net profit (loss) CNY -197.22 million CNY -34.71 million Worsened by CNY 162.51 million
Basic earnings per share (EPS) CNY -1.48 CNY -0.28 Decreased by CNY 1.20
Weighted average return on equity (ROE) -3.61% -0.85% Down 2.76 percentage points
Planned inventory impairment provision Over CNY 92 million - New significant charge
  • Large net loss: The CNY 197.22 million net loss in 2024 represents a material earnings shock versus 2023 and increases pressure on cash flow and balance sheet flexibility.
  • Negative EPS trajectory: Basic EPS fell to CNY -1.48, magnifying dilution risks for equity holders and weakening per-share metrics used by investors.
  • Declining ROE: A weighted average ROE of -3.61% (down 2.76 pp) signals underutilization of shareholder capital and reduced returns from core operations.
  • Inventory risk: A planned provision for inventory impairment of over CNY 92 million highlights inventory obsolescence and valuation risk tied to product cycles and demand forecasting.
  • Expense pressure from growth strategy: Continued heavy investment in R&D and market expansion has increased operating expenses, compressing margins in the near term.
  • Sector competition: Operating in the global semiconductor sector exposes the company to intense competition from established international players and agile local rivals, which can exert pricing pressure and accelerate product obsolescence.
Operational and financial transmission channels of these risks include:
  • Cash burn and working capital strain from high operating expenses and inventory write-downs.
  • Credit and refinancing risk if losses persist and leverage or covenant headroom tightens.
  • Market-share volatility in key segments due to aggressive pricing or faster product rollouts by competitors.
  • Execution risk on R&D: higher investment does not guarantee timely commercialization or revenue generation.
Key items for monitoring (near-term indicators):
  • Quarterly cash flow from operations and cash runway metrics.
  • Realized inventory turns and any further impairment announcements beyond the >CNY 92 million provision.
  • R&D capitalization vs. expensing trends and the timeline for product revenue recognition.
  • Gross margin stability amid competitive pricing and component cost volatility.
For additional context on shareholder composition and recent investor interest, see: Exploring 3Peak Incorporated Investor Profile: Who's Buying and Why?

3Peak Incorporated (688536.SS) Growth Opportunities

3Peak Incorporated (688536.SS) presents a compelling growth narrative driven by aggressive earnings acceleration, robust EPS improvement, targeted market positioning and continued R&D investment aligned with China's semiconductor self-sufficiency initiatives.

  • Analyst forecasts: earnings growth at 78.1% per annum and revenue growth at 27.1% per annum.
  • EPS expected to expand 77.7% per annum, reflecting margin expansion or share-base benefits.
  • Return on equity (ROE) forecasted to reach ~7.5% in three years, indicating improving capital efficiency from current levels.
  • Strategic focus on mid-to-high-end analog ICs positions the company to capture higher ASPs and domestic substitution demand.
  • Sustained R&D and go-to-market investment supports product breadth and capability to win design-ins with domestic OEMs.
Projection Year 1 Year 2 Year 3
Revenue growth (annual) 27.1% 27.1% 27.1%
Earnings growth (annual) 78.1% 78.1% 78.1%
EPS growth (annual) 77.7% 77.7% 77.7%
Forecast ROE ~3.5% (current baseline) ~5.5% ~7.5%

Key commercial and technical drivers:

  • R&D intensity: continued capex and headcount allocation toward analog IP and process adaptation.
  • Domestic content shift: advantage from China's policy push to localize semiconductor supply chains.
  • Product mix upgrade: deliberate targeting of mid-to-high-end analog sways ASPs and margins upward.
  • Channel & design-win expansion: proactive market presence aimed at long-term customer relationships.

Potential execution risks to monitor:

  • Execution on scale: translating high growth rates into stable cash flow and margin normalization.
  • Capital intensity: R&D and manufacturing investments may pressure free cash flow near term.
  • Competitive intensity: global analog incumbents and domestic peers could compress pricing and wins.
  • ROE sensitivity: ROE improvement depends on margin recovery and productive asset deployment.

For background context on the company's origins, ownership and business model, see: 3Peak Incorporated: History, Ownership, Mission, How It Works & Makes Money

DCF model

3Peak Incorporated (688536.SS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.